t-MDS and MDS patient accrual in published clinical trials
| Patient accrual . | Group A, n . | Group B, n . | Group C, n . | Total, N . |
|---|---|---|---|---|
| Completed trials (n = 4939) | ||||
| t-MDS | 0 | 143 | 35 | 178 |
| MDS | 1138 | 3299 | 502 | 4939 |
| Ongoing trials (n = 1183) | ||||
| t-MDS | 0 | 18 | 0 | 18 |
| MDS | 182 | 1001 | 0 | 1183 |
| Terminated trials (n = 313) | ||||
| t-MDS | 0 | 2 | 3 | 5 |
| MDS | 47 | 212 | 54 | 313 |
| Unknown trials (n = 737) | ||||
| t-MDS | 0 | 1 | 29 | 30 |
| MDS | 194 | 312 | 231 | 737 |
| Patient accrual . | Group A, n . | Group B, n . | Group C, n . | Total, N . |
|---|---|---|---|---|
| Completed trials (n = 4939) | ||||
| t-MDS | 0 | 143 | 35 | 178 |
| MDS | 1138 | 3299 | 502 | 4939 |
| Ongoing trials (n = 1183) | ||||
| t-MDS | 0 | 18 | 0 | 18 |
| MDS | 182 | 1001 | 0 | 1183 |
| Terminated trials (n = 313) | ||||
| t-MDS | 0 | 2 | 3 | 5 |
| MDS | 47 | 212 | 54 | 313 |
| Unknown trials (n = 737) | ||||
| t-MDS | 0 | 1 | 29 | 30 |
| MDS | 194 | 312 | 231 | 737 |